Skip to Content

Workers’ Compensation Board

Search menu

Subject Number 046-697 Temporary Suspension of Safa K. Naman, M.D.'s Authorization to Treat Injured Workers Effective June 30, 2014

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 167737-6W

June 26, 2014

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Safa Naman’s authorization to treat injured workers within the New York State workers’ compensation system effective June 30, 2014. Dr. Naman’s last known business address is 33 Mitchell Avenue, Binghamton, New York 13903.

The Chair's designee’s investigation revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) issued Order # 13-358, wherein Dr. Naman could not successfully defend against at least one of the charged acts of misconduct alleging negligence on more than one occasion. Effective November 12, 2013, Dr. Naman was ordered to practice medicine only at Article 28 facilities and thereafter, effective January 1, 2014, his medical license was limited precluding all patient contact and the practice of medicine clinical or otherwise. Dr. Naman may not use his medical license as a basis for practicing any other profession licensed or regulated by the New York State Board of Regents, Department of Health or the Department of State.

Therefore, the Chair believes that Dr. Naman may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Naman is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Naman for services rendered prior to June 30, 2014, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Naman for services rendered prior to June 30, 2014 should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

Robert E. Beloten
Chair